Dr Colin Coros, PhD, MBA, ICD.D, Chief Commercialization Officer at Nanostics Inc.
At Nanostics, Dr Coros is responsible leading the commercialization and business development efforts of the company. As a former Executive-In-Residence at TEC Edmonton, Dr Coros was part of the Health Accelerator program where he helped the commercialization efforts of a variety of health care related companies. Previous to that, Dr Coros was the CEO of the Delta Genomics a national, biobanking, genotyping, and sequencing company for the livestock industry. Dr Coros is also the co-founder of Helios Genomics a metagenomics company specializing in environmental microbial testing. His educational background includes a PhD in Biochemistry from the University of Western Ontario and an MBA degree specializing in Biotechnology from the Edwards School of Business at the University of Saskatchewan.